Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Dermatol Surg ; 42(1): 59-62, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26673435

ABSTRACT

BACKGROUND: Digital mucous cysts (digital myxoid cysts or DMCs) are benign cystic swellings typically affecting the digital distal interphalangeal joint or the proximal nail fold. Many treatment modalities exist; however, permanent scarring, wound infection, and recurrence are common. Polidocanol sclerotherapy has been reported as a potential treatment. OBJECTIVE: To assess the efficacy and safety of percutaneous polidocanol sclerotherapy in the treatment of DMC. MATERIALS AND METHODS: The authors performed polidocanol sclerotherapy in 63 patients (23 men and 40 women). For each patient, the DMC contents were extruded and 3% polidocanol (0.02-0.5 mL) was injected to gently refill the cyst to its previous size. Subjects were reviewed after 6 weeks and offered a second treatment if necessary, and reviewed again after 12 weeks. Changes in lesions and adverse reactions were noted. RESULTS: Of the 63 subjects treated, 43 (68.3%) experienced complete resolution of the cyst by 6 weeks, and 49 (77.8%) experienced complete resolution by 12 weeks. Side effects were minor and had resolved in all patients by 12-week review. CONCLUSION: Percutaneous polidocanol sclerotherapy is a simple, safe, and effective approach to treating DMC, and is suitable for office-based practice.


Subject(s)
Ganglion Cysts/therapy , Polyethylene Glycols/administration & dosage , Sclerosing Solutions/administration & dosage , Sclerotherapy/methods , Administration, Cutaneous , Adult , Aged , Aged, 80 and over , Female , Fingers , Humans , Male , Middle Aged , Polidocanol , Treatment Outcome , Young Adult
4.
Am J Med Genet A ; 143A(10): 1114-9, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17431922

ABSTRACT

We report on two unrelated families with EEC syndrome (ectrodactyly, ectodermal dysplasia, cleft lip/palate), each with an Arg227Gln TP63 gene mutation, where the phenotype overlapped extensively with the allelic disorder, limb-mammary syndrome (LMS). Features common to both families were an ectodermal dysplasia principally affecting tooth, breast and nipple development, dacryostenosis and severe micturition difficulties. Additional findings included post-axial digital hypoplasia, cleft uvula, anal stenosis, hypoplasia of the perineal body and biopsy-proven interstitial cystitis. No individual had cleft lip. Split hand-split foot malformation (SHFM) occurred in one child-born after the molecular diagnosis was established. Unlike previous reports, the urinary symptoms were refractory to treatment with oral Fibrase and persisted into adulthood. Of the six cases/families now reported with EEC syndrome and Arg227Gln TP63 mutation, four have manifested this distinct urological abnormality, indicative of a genotype-phenotype correlation.


Subject(s)
Abnormalities, Multiple/genetics , Cleft Lip/genetics , Cleft Palate/genetics , DNA-Binding Proteins/genetics , Ectodermal Dysplasia/genetics , Fingers/abnormalities , Trans-Activators/genetics , Tumor Suppressor Proteins/genetics , Urination Disorders/genetics , Adult , Arginine/genetics , Child, Preschool , Female , Genotype , Glutamine/genetics , Humans , Infant , Male , Middle Aged , Pedigree , Phenotype , Point Mutation , Syndrome , Transcription Factors
SELECTION OF CITATIONS
SEARCH DETAIL